Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001091818-23-000146
Filing Date
2023-08-01
Accepted
2023-08-01 15:11:13
Documents
34
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 QTR. REPORT - JUNE 30, 2023 bfnh20230630.htm   iXBRL 10-Q 313481
2 CERTIFICATION ex311.htm EX-31.1 4757
3 CERTIFICATION ex312.htm EX-31.2 4952
4 CERTIFICATION ex321.htm EX-32.1 2022
5 CERTIFICATION ex322.htm EX-32.2 1940
11 bfnhlogo2019001.jpg GRAPHIC 21193
  Complete submission text file 0001091818-23-000146.txt   1505116

Data Files

Seq Description Document Type Size
6 bfnh-20230630.xsd EX-101.SCH 10763
7 bfnh-20230630_cal.xml EX-101.CAL 18901
8 bfnh-20230630_def.xml EX-101.DEF 18842
9 bfnh-20230630_lab.xml EX-101.LAB 101919
10 bfnh-20230630_pre.xml EX-101.PRE 74805
28 EXTRACTED XBRL INSTANCE DOCUMENT bfnh20230630_htm.xml XML 95831
Mailing Address 2020 GENERAL BOOTH BLVD SUITE 230 VIRGINIA BEACH VA 23454
Business Address 2020 GENERAL BOOTH BLVD SUITE 230 VIRGINIA BEACH VA 23454 757-306-6090
BIOFORCE NANOSCIENCES HOLDINGS, INC. (Filer) CIK: 0001310488 (see all company filings)

EIN.: 852138858 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51074 | Film No.: 231131261
SIC: 3826 Laboratory Analytical Instruments